Zobrazeno 1 - 10
of 194
pro vyhledávání: '"therapy-related cardiac dysfunction"'
Autor:
Xander Jacquemyn, Bhargava K. Chinni, Benjamin T. Barnes, Sruti Rao, Shelby Kutty, Cedric Manlhiot
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Background Anthracyclines are essential in pediatric cancer treatment, but patients are at risk cancer therapy-related cardiac dysfunction (CTRCD). Standardized definitions by the International Cardio-Oncology Society (IC-OS) aim to enhance
Externí odkaz:
https://doaj.org/article/5bef8372931f4332846735c7f9980dbd
Autor:
Michelle Bloom, Jose A. Alvarez-Cardona, Sarju Ganatra, Ana Barac, Iskra Pusic, Daniel Lenihan, Susan Dent
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-6 (2024)
Abstract Heart failure (HF) in patients with cancer is associated with high morbidity and mortality. The success of cancer therapy has resulted in an exponential rise in the population of cancer survivors, however cardiovascular disease (CVD) is now
Externí odkaz:
https://doaj.org/article/f3a584b5941c46819cccf9e938764430
Autor:
B. A. Akbalaeva, L. V. Shulzhenko, I. V. Pershukov, N. Raiimbek uulu, T. A. Batyraliev, O. V. Gurovich, V. V. Vinogradskaia, N. T. Jainakbayev, A. O. Seidalin, M. R. Kamaliyeva
Publikováno v:
Инновационная медицина Кубани, Vol 0, Iss 2, Pp 8-15 (2024)
Background: Cancer therapy-related cardiac dysfunction (CTRCD) is a new term that encompasses a wide range of potential manifestations and is etiologically associated with a wide variety of cancer treatments. Detection of early subclinical cardiac dy
Externí odkaz:
https://doaj.org/article/486c8a46f0c24822b38766fdb3ad6a00
Autor:
Hanne M. Boen, Maaike Alaerts, Inge Goovaerts, Johan B. Saenen, Constantijn Franssen, Anne Vorlat, Tom Vermeulen, Hein Heidbuchel, Lut Van Laer, Bart Loeys, Emeline M. Van Craenenbroeck
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-12 (2024)
Abstract Background Variants in cardiomyopathy genes have been identified in patients with cancer therapy-related cardiac dysfunction (CTRCD), suggesting a genetic predisposition for the development of CTRCD. The diagnostic yield of genetic testing i
Externí odkaz:
https://doaj.org/article/d722bd93cc5b4cb3bf0e63ce250ce1f0
Autor:
Xander Jacquemyn, Junzhen Zhan, Jef Van den Eynde, Kyla Cordrey, Rita Long, Sruti Rao, Benjamin T. Barnes, W. Reid Thompson, David Danford, Shelby Kutty
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 53, Iss , Pp 101436- (2024)
Background: Anthracyclines are associated with cardiac dysfunction. Little is known about the interplay of pre-existing hypertension and treatment response. We aimed to investigate the relationship between hypertension and the development of cancer t
Externí odkaz:
https://doaj.org/article/7b5c53bf121a4a58b56979c487cfa04b
Autor:
I. V. Pershukov, B. A. Akbalaeva, L. V. Shulzhenko, T. A. Batyraliev, O. V. Gurovich, V. V. Vinogradskaia, Z. A. Karben, D. V. Fettser, T. N. Kuznetsova, E. Yu. Ivanenkova, N. Raiimbek uulu, M. V. Kvasova, R. K. Kalmatov, Ja. B. Imetova, S. M. Mamatova, N. T. Jainakbayev, A. O. Seidalin, N. N. Rakhalskaya
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 6 (2024)
Aim. To assess the incidence and timing of subclinical cardiac dysfunction associated with therapy for HER2-positive locally advanced or metastatic breast cancer, and to analyze the difference in time from significant reduction in left ventricular (L
Externí odkaz:
https://doaj.org/article/466b8f957d5942a4b5b505f81340b325
Autor:
Yunjing Shi, Zeping Qiu, Jing Yu, Zhuojin Li, Sha Hua, Yanjia Chen, Xiaosong Chen, Kunwei Shen, Wei Jin
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Insulin resistance is an overlapping risk factor for both heart and breast cancer, while its interaction with cardiotoxicity in breast cancer (BC) patients is not clear. This study investigated the impact of insulin resistance on
Externí odkaz:
https://doaj.org/article/5e584331d62b46a89e891952e3750cb7
Autor:
Shinjeong Song, Joohyun Woo, HyunGoo Kim, Jun Woo Lee, Woosung Lim, Byung-In Moon, Kihwan Kwon
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundDoxorubicin is a highly effective anti-cancer drug that causes left ventricular (LV) dysfunction and induces late-onset cardiomyopathy. However, an effective and clinically applicable preventive treatment is yet to be discovered.ObjectiveCa
Externí odkaz:
https://doaj.org/article/564876b43b4b4f7cb14381021057f587
Autor:
Kei Nakata, Selcuk Kucukseymen, Xiaoying Cai, Tuyen Yankama, Jennifer Rodriguez, Eiryu Sai, Patrick Pierce, Long Ngo, Shiro Nakamori, Nadine Tung, Warren J. Manning, Reza Nezafat
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 26, Iss 1, Pp 101033- (2024)
ABSTRACT: Background: Left ventricular ejection fraction (LVEF) is the most commonly clinically used imaging parameter for assessing cancer therapy-related cardiac dysfunction (CTRCD). However, LVEF declines may occur late, after substantial injury.
Externí odkaz:
https://doaj.org/article/76aa526a21e64b3c8b8f08ae9a645c93
Publikováno v:
КардиоСоматика, Vol 13, Iss 3, Pp 176-180 (2023)
Background. As is known, the treatment of the oncological process leads either to the occurrence of cardiovascular pathology, or to an increase in the risk of death from cardiovascular diseases. Currently, the concept of ˝cardiovascular toxicity˝ h
Externí odkaz:
https://doaj.org/article/273a0d6cd9014a4aa607dde64f7c7736